Miljöpåverkan
Alfuzosin
Miljörisk:
Användning av alfuzosin har bedömts medföra försumbar risk för miljöpåverkan.
Nedbrytning:
Det kan inte uteslutas att alfuzosin är persistent, då data saknas.
Bioackumulering:
Alfuzosin har låg potential att bioackumuleras.
Läs mer
Detaljerad miljöinformation
Environmental Risk Classification
Predicted Environmental Concentration (PEC)
PEC is calculated according to the following formula:
PEC (µg/L) = (A*109*(100-R))/(365*P*V*D*100) = 1.37*10-6*A*(100-R)
PEC = 0.05676 μg/L
Where:
A = 414,3148 kg (total sold amount API in Sweden year 2021, data from IQVIA)
R = 0% removal rate (due to loss by adsorption to sludge particles, by volatilization, hydrolysis or biodegradation)
P = number of inhabitants in Sweden = 10*106
V (L/day) = volume of wastewater per capita and day = 200 (ECHA default) (Ref I)
D = factor of dilution of waste water by surface water flow = 10 (ECHA default) (Ref I)
Predicted No Effect Concentration (PNEC)
Ecotoxicological studies
Algae (Pseudokirchnerellia subcapitata):
EC50 72 h (cell density): 52 700 μg/L
EC50 72 h (area under the growth curve): 46 700 μg/L
EC50 72h (growth rate): > 76 600 µg/L
NOEC72h (biomass): 17 200 µg/L
NOEC72 (growth rate): 36 300 µg/L
(Protocol: OECD 201)
(Ref II)
Crustacean (Daphnia magna):
EC50 48 h (acute immobilization): 314 000 μg/L
(Protocol: OECD 202)
(Ref III)
NOEC21d reproduction per introduced adult: 4 000 µg/L
NOEC21d reproduction per surviving adult ≥ 10 000 µg/L
NOEC21d mortality of adults ≥ 10 000 µg/L
(Ref VII)
Fish (Oncorhynchus mykiss):
LC50 96 h (mortatlity): 1 020 000 μg/L
(Protocol: OECD 203/FDA 4.11)
(Ref IV)
Other ecotoxicity data:
PNEC = 4 000 μg/L /50=80 μg/L
The PNEC (μg/L) was calculated using results from the most sensitive chronic toxicity endpoint and an assessment factor of 50 (two long-term results from species representing two trophic levels). The most sensitive species was Daphnia magna for which the NOEC(21d) was 4 000 μg/L.
Environmental Risk Classification (PEC/PNEC ratio)
PEC/PNEC= 0.05676/80 = 7.1*10-4
PEC/PNEC ≤ 0.1 which justifies the phrase “Use of alfuzosin has been considered to result in insignificant environmental risk”
Degradation
No data available. Therefore, the summary phrase for degradation should be: "The potential for persistence of alfuzosin cannot be excluded, due to lack of data"
Bioaccumulation
Partition coefficient:
Alfuzosin has low potential for bioaccumulation, as indicated by a log Kow of 1.51 at pH 7.4 (experimentally determined by HPLC) (Ref V)
Excretion (metabolism)
Alfuzosin is excreted to 10% as parent compound in urine. There are three metabolic pathways: oxidation, O-demethylation and N-dealkylation. Metabolites are mostly excreted in the feces (75 to 91%). The metabolites are pharmacologically inactive. (Ref VI)
References
-
ECHA, European Chemicals Agency, 2008 Guidance on information requirements and chemical safety assessment. https://echa.europa.eu/guidance-documents/guidance-on-reach
-
Sanofi Internal Report: “Toxicity of Alfuzosin to the unicellular green alga, Pseudokirchneriella subcapitata” (OECD 201) (2006)
-
Sanofi Internal Report: “Acute toxicity of Alfuzosin to the water flea, Daphnia magna, determined under static test conditions” (OECD 202/FDA 4.08) (2006)
-
Sanofi Internal Report: “Acute toxicity of Alfuzosin to the rainbow trout, Oncorhynchus mykiss, determined under static test conditions” (OECD 203/FDA 4.11) (2006)
-
Sanofi Internal Report: "Xatral-product monograph" (Rev 2014)
-
McKeage K. and Plosker G. L. (2002) “Alfuzosin, a review of the therapeutic use of the prolonged-release formulation given once daily in the management of benign prostatic hyperplasia” Drugs 62 (4): 633-653
-
Ref: Sanofi, internal report: Alfuzosine HCL: Effect on Daphnia magna in a Semi-Static Reproduction Test. OECD 211. Report #143662221 August 2022